Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001402972 | SCV001604832 | likely benign | PTEN hamartoma tumor syndrome | 2024-11-09 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002259114 | SCV002528213 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-11 | criteria provided, single submitter | curation | |
Color Diagnostics, |
RCV002259114 | SCV004357073 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002259114 | SCV005034350 | likely benign | Hereditary cancer-predisposing syndrome | 2024-02-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |